Universal Health Services (UHS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 28, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UHS SEC filings page.
Universal Health Services, Inc. (UHS) reported $18.1B in revenue over the twelve months to Jun 30, 2026, up 10.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
UHS turned revenue growth into faster profit growth, while FY2025 exposed a cash-conversion setback and tighter short-term balance-sheet flexibility.
From FY2023 to FY2025, operating margin rose 3.3 percentage points while revenue increased21.6% , showing costs were absorbed more efficiently as the business expanded. Yet in FY2025, operating cash flow fell9.8% and free cash flow fell24.4% , so profit growth and cash generation stopped moving in lockstep.
FY2025 net income reached
Capital expenditures rose
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Universal Health Services, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Universal Health Services, Inc. has an operating margin of 11.5%, meaning the company retains $11 of operating profit per $100 of revenue. This strong profitability earns a score of 70/100, reflecting efficient cost management and pricing power. This is up from 10.6% the prior year.
Universal Health Services, Inc.'s revenue grew 9.7% year-over-year to $17.4B, a solid pace of expansion. This earns a growth score of 65/100.
Universal Health Services, Inc. has a moderate D/E ratio of 0.55. This balance of debt and equity financing earns a leverage score of 37/100.
Universal Health Services, Inc.'s current ratio of 1.05 is below the typical benchmark, resulting in a score of 21/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Universal Health Services, Inc. has a free cash flow margin of 4.9%, earning a moderate score of 47/100. The company generates positive cash flow after capital investments, but with room for improvement.
Universal Health Services, Inc. earns a strong 20.5% return on equity (ROE), meaning it generates $20 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is up from 17.1% the prior year.
Universal Health Services, Inc. scores 3.01, well above the 2.99 safe threshold. The largest contribution to the score comes from revenue of $17.4B against total assets of $15.5B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Universal Health Services, Inc. passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, Universal Health Services, Inc. generates $1.25 in operating cash flow ($1.9B OCF vs $1.5B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Universal Health Services, Inc. earns $12.78 in operating income for every $1 of interest expense ($2.0B vs $156.1M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Universal Health Services, Inc. generated $4.6B in revenue in Q2 2026. This represents an increase of 8.3% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.
Universal Health Services, Inc.'s EBITDA was $684.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.9% from the same quarter a year earlier. Against the prior quarter it is up 3.9%.
Universal Health Services, Inc. reported $358.4M in net income in Q2 2026. This represents an increase of 1.5% from the same quarter a year earlier. Against the prior quarter it is up 2.8%.
Universal Health Services, Inc. earned $5.98 per diluted share (EPS) in Q2 2026. This represents an increase of 10.1% from the same quarter a year earlier. Against the prior quarter it is up 5.8%.
Cash & Balance Sheet
Universal Health Services, Inc. generated $215.7M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 23.8% from the same quarter a year earlier. Against the prior quarter it is up 16.9%.
Universal Health Services, Inc. held $138.8M in cash against $4.1B in long-term debt as of Q2 2026.
Universal Health Services, Inc. paid $0.20 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Universal Health Services, Inc.'s operating margin was 11.1% in Q2 2026, reflecting core business profitability. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.
Universal Health Services, Inc.'s net profit margin was 7.7% in Q2 2026, showing the share of revenue converted to profit. This is down 0.5 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.
Universal Health Services, Inc.'s quarterly ROE was 4.8% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.
Not reported for Q2 2026.
Capital Allocation
Universal Health Services, Inc. spent $320.8M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 106.7% from the same quarter a year earlier. Against the prior quarter it is up 95.8%.
Universal Health Services, Inc. invested $227.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 14.4% from the same quarter a year earlier. Against the prior quarter it is up 4.8%.
Not reported for Q2 2026.
UHS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6B+8.3% | $4.5B+9.6% | $4.5B+9.1% | $4.5B+13.4% | $4.3B+9.6% | $4.1B+6.7% | $4.1B+11.1% | $4.0B+11.2% |
| Operating Income | $516.7M+3.3% | $502.9M+10.6% | $517.2M+9.5% | $521.7M+35.8% | $500.3M+14.6% | $454.8M+17.0% | $472.5M+42.7% | $384.2M+34.6% |
| EBITDA | $684.0M+4.9% | $658.3M+9.1% | $680.6M+9.9% | $676.7M+26.8% | $652.3M+11.7% | $603.2M+13.9% | $619.3M+29.9% | $533.7M+26.3% |
| Interest Expense | $39.9M+12.9% | $37.1M-7.3% | $42.2M+6.3% | $38.4M-13.9% | $35.4M-27.7% | $40.1M-24.2% | $39.7M-25.9% | $44.7M-16.3% |
| Income Tax | $114.5M+3.4% | $110.4M+11.8% | $133.6M+31.9% | $117.8M+55.7% | $110.8M+26.3% | $98.8M+40.6% | $101.3M+64.7% | $75.6M+44.0% |
| Net Income | $358.4M+1.5% | $348.7M+10.1% | $445.9M+34.2% | $373.0M+44.2% | $353.2M+22.2% | $316.7M+20.9% | $332.4M+53.6% | $258.7M+54.9% |
| EPS (Basic) | $6.01+9.5% | $5.71+17.2% | $7.15+41.6% | $5.92+52.2% | $5.49+27.1% | $4.87+24.9% | $5.05+59.3% | $3.89+60.7% |
| EPS (Diluted) | $5.98+10.1% | $5.65+17.7% | $7.03+42.3% | $5.86+54.2% | $5.43+27.5% | $4.80+25.7% | $4.94+57.3% | $3.80+58.3% |
| Diluted Shares (Avg) | 60M-7.8% | 62M-6.6% | N/A | 64M-6.5% | 65M-4.3% | 66M-3.6% | N/A | 68M-2.2% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses.
UHS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.9B+6.3% | $15.7B+5.4% | $15.5B+7.3% | $15.3B+6.9% | $15.0B+6.5% | $14.9B+5.9% | $14.5B+3.6% | $14.4B+3.5% |
| Current Assets | $3.7B+23.1% | $3.5B+13.7% | $3.4B+21.0% | $3.3B+16.3% | $3.0B+9.1% | $3.1B+7.2% | $2.8B+0.2% | $2.8B+1.8% |
| Cash & Equivalents | $138.8M+0.9% | $119.0M-6.1% | $137.8M+9.4% | $112.9M+6.4% | $137.6M+6.8% | $126.8M+13.1% | $126.0M+5.5% | $106.1M+31.3% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Accounts Receivable | $2.8B+21.7% | $2.7B+13.8% | $2.6B+19.5% | $2.6B+16.8% | $2.3B+6.7% | $2.4B+4.9% | $2.2B-2.7% | $2.2B-0.9% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $4.0B+0.1% | $4.0B+0.8% | $4.0B+1.5% | $4.0B+0.6% | $4.0B+0.9% | $3.9B+0.5% | $3.9B0.0% | $4.0B+1.4% |
| Total Liabilities | $8.4B+5.9% | $8.2B+1.6% | $8.3B+5.7% | $8.2B+5.5% | $8.0B+4.9% | $8.1B+3.9% | $7.8B-0.2% | $7.7B-0.8% |
| Current Liabilities | $3.3B+42.3% | $3.2B+39.2% | $3.2B+46.6% | $3.2B+57.1% | $2.3B+7.8% | $2.3B+12.3% | $2.2B+9.8% | $2.0B+1.1% |
| Non-Current Liabilities | $5.1B-9.1% | $5.0B-13.7% | $5.0B-10.4% | $5.0B-12.6% | $5.6B+3.7% | $5.8B+0.8% | $5.6B-3.7% | $5.7B-1.4% |
| Long-Term Debt | $4.1B-10.2% | $4.0B-14.3% | $4.0B-10.3% | $4.0B-14.4% | $4.5B+2.8% | $4.6B-2.6% | $4.5B-6.7% | $4.6B-3.7% |
| Total Equity | $7.5B+6.9% | $7.5B+10.0% | $7.3B+9.1% | $7.2B+8.5% | $7.0B+8.4% | $6.8B+8.5% | $6.7B+8.4% | $6.6B+8.9% |
| Retained Earnings | N/A | N/A | $8.0B+8.4% | N/A | N/A | N/A | $7.4B+8.4% | N/A |
Not reported in any period shown, so not listed: Inventory.
UHS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $443.3M-19.2% | $401.6M+11.5% | $574.7M-12.7% | $380.7M+14.3% | $549.0M-19.2% | $360.0M-9.2% | $658.4M+45.5% | $333.0M+106.0% |
| Depreciation & Amortization | $167.3M+10.1% | $155.4M+4.8% | $163.3M+11.3% | $155.1M+3.7% | $152.0M+3.1% | $148.3M+5.2% | $146.8M+0.9% | $149.6M+9.0% |
| Stock-Based Compensation | N/A | $22.5M+4.2% | N/A | N/A | N/A | $21.6M+10.0% | N/A | N/A |
| Capital Expenditures | $227.6M-14.4% | $217.2M-9.1% | $281.2M+14.3% | $228.9M-7.7% | $266.0M+10.2% | $239.0M+14.6% | $245.9M+19.2% | $247.9M+24.0% |
| Free Cash Flow | $215.7M-23.8% | $184.5M+52.4% | $293.5M-28.9% | $151.8M+78.5% | $283.0M-35.4% | $121.0M-35.6% | $412.5M+67.7% | $85.0Mn/m |
| Investing Cash Flow | -$234.2Mn/m | -$197.6Mn/m | -$224.0Mn/m | -$269.4Mn/m | -$305.9Mn/m | -$271.3Mn/m | -$208.0Mn/m | -$265.6Mn/m |
| Financing Cash Flow | -$189.5Mn/m | -$221.9Mn/m | -$296.1Mn/m | -$134.5Mn/m | -$227.7Mn/m | -$91.4Mn/m | -$426.8Mn/m | -$89.7M-598.9% |
| Dividends Paid | $11.9M-9.2% | $13.0M-4.1% | $12.4M-5.2% | $12.7M-5.8% | $13.1M-3.4% | $13.5M-0.5% | $13.0M-3.5% | $13.5M-2.4% |
| Share Buybacks | $320.8M+106.7% | $163.8M-26.7% | $352.0M+40.7% | $237.4M+30.0% | $155.2M+61.8% | $223.4M+57.2% | $250.2M+54.4% | $182.6M+4.0% |
UHS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1%-0.5pp | 11.2%+0.1pp | 11.5%0.0pp | 11.6%+1.9pp | 11.7%+0.5pp | 11.1%+1.0pp | 11.5%+2.6pp | 9.7%+1.7pp |
| Net Margin | 7.7%-0.5pp | 7.8%0.0pp | 9.9%+1.9pp | 8.3%+1.8pp | 8.3%+0.9pp | 7.7%+0.9pp | 8.1%+2.2pp | 6.5%+1.8pp |
| Return on Equity | 4.8%-0.3pp | 4.7%0.0pp | 6.1%+1.1pp | 5.2%+1.3pp | 5.0%+0.6pp | 4.7%+0.5pp | 5.0%+1.5pp | 3.9%+1.2pp |
| Return on Assets | 2.3%-0.1pp | 2.2%+0.1pp | 2.9%+0.6pp | 2.4%+0.6pp | 2.4%+0.3pp | 2.1%+0.3pp | 2.3%+0.8pp | 1.8%+0.6pp |
| Current Ratio | 1.12-0.2x | 1.08-0.2x | 1.05-0.2x | 1.03-0.4x | 1.290.0x | 1.32-0.1x | 1.27-0.1x | 1.390.0x |
| Debt-to-Equity | 0.54-0.1x | 0.53-0.1x | 0.55-0.1x | 0.55-0.1x | 0.650.0x | 0.68-0.1x | 0.67-0.1x | 0.70-0.1x |
| Liabilities-to-Equity | 1.120.0x | 1.10-0.1x | 1.130.0x | 1.140.0x | 1.130.0x | 1.19-0.1x | 1.17-0.1x | 1.17-0.1x |
| Asset Turnover | 0.290.0x | 0.290.0x | 0.290.0x | 0.290.0x | 0.290.0x | 0.280.0x | 0.280.0x | 0.280.0x |
| FCF Margin | 4.7%-2.0pp | 4.1%+1.2pp | 6.5%-3.5pp | 3.4%+1.2pp | 6.6%-4.6pp | 2.9%-1.9pp | 10.0%+3.4pp | 2.1%+3.2pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Universal Health Services, Inc. UHS | FY2025 | $17.4B | $1.5B | 8.6% | $10.1B | 53/100 |
| Encompass Health Corporation EHC | FY2025 | $5.9B | $566.2M | 9.5% | $12.0B | 59/100 |
| Tenet Healthcare Corporation New THC | FY2025 | $21.3B | $1.4B | 6.6% | $21.6B | 56/100 |
| Fresenius Medical Care AG FMS | FY2025 | $23.0B | $1.1B | 5.0% | $12.0B | 49/100 |
| The Ensign Group, Inc. ENSG | FY2025 | $5.1B | $344.0M | 6.8% | $10.7B | 69/100 |
| HCA Healthcare, Inc. HCA | FY2025 | $75.6B | $6.8B | 9.0% | $100.3B | 62/100 |
Where Universal Health Services, Inc. Ranks
Frequently Asked Questions
What is Universal Health Services, Inc.'s annual revenue?
Universal Health Services, Inc. (UHS) reported $17.4B in total revenue for fiscal year 2025. This represents a 9.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Universal Health Services, Inc.'s revenue growing?
Universal Health Services, Inc. (UHS) revenue grew by 9.7% year-over-year, from $15.8B to $17.4B in fiscal year 2025.
Is Universal Health Services, Inc. profitable?
Yes, Universal Health Services, Inc. (UHS) reported a net income of $1.5B over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $1.5B, with a net profit margin of 8.6%.
What is Universal Health Services, Inc.'s EBITDA?
Universal Health Services, Inc. (UHS) had EBITDA of $2.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Universal Health Services, Inc. have?
As of fiscal year 2025, Universal Health Services, Inc. (UHS) had $137.8M in cash and equivalents against $4.0B in long-term debt.
What is Universal Health Services, Inc.'s operating margin?
Universal Health Services, Inc. (UHS) had an operating margin of 11.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Universal Health Services, Inc.'s net profit margin?
Universal Health Services, Inc. (UHS) had a net profit margin of 8.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Universal Health Services, Inc. pay dividends?
Yes, Universal Health Services, Inc. (UHS) paid $0.80 per share in dividends during fiscal year 2025.
What is Universal Health Services, Inc.'s return on equity (ROE)?
Universal Health Services, Inc. (UHS) has a return on equity of 20.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Universal Health Services, Inc.'s free cash flow?
Universal Health Services, Inc. (UHS) generated $849.2M in free cash flow during fiscal year 2025. This represents a -24.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Universal Health Services, Inc.'s operating cash flow?
Universal Health Services, Inc. (UHS) generated $1.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Universal Health Services, Inc.'s total assets?
Universal Health Services, Inc. (UHS) had $15.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Universal Health Services, Inc.'s capital expenditures?
Universal Health Services, Inc. (UHS) invested $1.0B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Universal Health Services, Inc.'s current ratio?
Universal Health Services, Inc. (UHS) had a current ratio of 1.05 as of fiscal year 2025, which is considered adequate.
What is Universal Health Services, Inc.'s debt-to-equity ratio?
Universal Health Services, Inc. (UHS) had a debt-to-equity ratio of 0.55 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Universal Health Services, Inc.'s liabilities-to-equity ratio?
Universal Health Services, Inc. (UHS) had a liabilities-to-equity ratio of 1.13 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Universal Health Services, Inc.'s return on assets (ROA)?
Universal Health Services, Inc. (UHS) had a return on assets of 9.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Universal Health Services, Inc.'s P/E ratio?
Universal Health Services, Inc. (UHS) trades at 6.6x earnings, its market capitalization divided by $1.5B net income, trailing 12 months to June 30, 2026. The market capitalization is $10.1B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Universal Health Services, Inc.'s price-to-sales ratio?
Universal Health Services, Inc. (UHS) trades at 0.6x sales, its market capitalization divided by $18.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $10.1B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Universal Health Services, Inc.'s Altman Z-Score?
Universal Health Services, Inc. (UHS) has an Altman Z-Score of 3.01, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Universal Health Services, Inc.'s Piotroski F-Score?
Universal Health Services, Inc. (UHS) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Universal Health Services, Inc.'s earnings high quality?
Universal Health Services, Inc. (UHS) has an earnings quality ratio of 1.25x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Universal Health Services, Inc. cover its interest payments?
Universal Health Services, Inc. (UHS) has an interest coverage ratio of 12.78x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Universal Health Services, Inc.?
Universal Health Services, Inc. (UHS) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.